🇺🇸 Progesterone in oil in United States

44 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Fatigue — 6 reports (13.64%)
  2. Urticaria — 5 reports (11.36%)
  3. Vaginal Haemorrhage — 5 reports (11.36%)
  4. Drug Exposure During Pregnancy — 4 reports (9.09%)
  5. Drug Ineffective — 4 reports (9.09%)
  6. Dyspnoea — 4 reports (9.09%)
  7. Eosinophilic Pneumonia Acute — 4 reports (9.09%)
  8. Foetal Exposure During Pregnancy — 4 reports (9.09%)
  9. Hypersensitivity — 4 reports (9.09%)
  10. Pruritus — 4 reports (9.09%)

Source database →

Progesterone in oil in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Progesterone in oil approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Progesterone in oil in United States?

Toronto Centre for Advanced Reproductive Technology is the originator. The local marketing authorisation holder may differ — check the official source linked above.